Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
WELL Health Subsidiary WELLSTAR Expands National Billing Platform with Two Strategic Acquisitions, Now Serving Six Provinces
Microbix Presents Reference-Material Innovations at EUROGIN
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
BioNxt Signs Strategic Agreement for Eurasian Commercialization Following Cladribine ODF Patent Grant in Eurasia and Europe
Innocan closes $450,000 (U.S.) debenture offering
Sona Nanotech to hold investor webinar March 18
Quipt completes take-private deal w/ Kingswood, Forager
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager
MedX Announces Application for Extension of Non-Brokered Private Placement